首頁 > 市場調查報告書 > 醫療設備

市場調查報告書

商品編碼

1542926

全球皮膚鏡設備市場 - 2024-2031

Global Dermatoscope Devices Market - 2024-2031

出版日期: 2024年08月26日 | 出版商:

DataM Intelligence | 英文 187 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

市場概況

2023年，全球皮膚鏡設備市場達到9.7129億美元，預計到2031年將達到19.3089億美元，2024-2031年預測期間複合年成長率為9.2%。

皮膚鏡設備是用於詳細檢查皮膚的專用醫療儀器。它們提供皮膚病變、痣和其他皮膚異常的放大視圖，從而更好地可視化肉眼可能不可見的表面和地下結構。皮膚鏡的主要目的是幫助早期發現、診斷和監測各種皮膚狀況，包括皮膚癌、良性病變、發炎性皮膚病和感染性疾病。

皮膚鏡設備通常由放大鏡系統組成，通常帶有偏振或非偏振光源，這有助於減少眩光並增強皮膚結構的可見度。一些皮鏡還具有數位成像功能，可以捕獲和儲存高解析度影像，用於記錄、分析和遠端諮詢目的。這些設備有多種形式，包括用於攜帶式使用的手持式型號和用於更全面檢查的桌上型型號。它們在提高診斷準確性、指導活體組織切片決策和監測治療反應方面發揮著至關重要的作用。

市場動態：

司機

皮鏡設備不斷進步

皮鏡設備的不斷進步預計將在預測期內推動市場發展。先進的皮膚鏡設備結合了偏振和非偏振光源、交叉偏振和可調節放大倍率等功能，可以更好地可視化和表徵皮膚病變。這提高了診斷準確性，特別是在區分良性和惡性病變方面。

此外，一些先進的皮膚鏡設備利用人工智慧 (AI) 演算法進行自動病變分析和決策支援。人工智慧支援的功能有助於病變分類、風險分層和治療建議，補充醫療保健提供者的專業知識，並有可能改善診斷結果。

例如，2024 年 1 月 17 日，私人設備製造商 DermaSensor 的使用人工智慧檢測皮膚癌的手持設備獲得了美國食品和藥物管理局的批准。這家總部位於邁阿密的私人公司的設備也稱為 DermaSensor，利用光和人工智慧驅動的演算法來幫助基層醫療醫師識別可疑痣或病變中是否存在癌症。

許多現代皮鏡設備都配備了數位成像功能，可實現高解析度影像擷取和儲存。與電子健康記錄和遠距醫療平台的整合有助於無縫記錄、分析和遠端諮詢，從而提高工作流程效率和患者護理。

此外，各種皮膚癌和皮膚病的盛行率不斷增加、FDA 對新型設備的批准不斷增加、人們對皮膚鏡設備的認知不斷提高以及開發更多皮膚鏡設備的技術進步，預計將在預測期內推動市場發展。

限制

對替代方法的偏好、與皮鏡設備相關的高成本、監管挑戰、對皮鏡設備的認知有限以及與這些設備相關的技術挑戰等因素預計會阻礙市場。

Market Overview

The Global Dermatoscope Devices Market reached US$ 971.29 million in 2023 and is expected to reach US$ 1,930.89 million by 2031, growing at a CAGR of 9.2% during the forecast period 2024-2031.

Dermatoscope devices are specialized medical instruments used to examine the skin in detail. They provide magnified views of skin lesions, moles and other skin abnormalities, enabling better visualization of surface and subsurface structures that may not be visible to the naked eye. The primary purpose of dermatoscopes is to aid in the early detection, diagnosis and monitoring of various skin conditions, including skin cancer, as well as benign lesions, inflammatory skin diseases and infectious conditions.

Dermatoscope devices typically consist of a magnifying lens system, often with polarized or non-polarized light sources, which help to reduce glare and enhance the visibility of skin structures. Some dermatoscopes also incorporate digital imaging capabilities, allowing for the capture and storage of high-resolution images for documentation, analysis and remote consultation purposes. These devices come in various forms, including handheld models for portable use and desktop models for more comprehensive examinations. They play a crucial role in improving diagnostic accuracy, guiding biopsy decisions and monitoring treatment responses.

Market Dynamics: Drivers

Rising advancements in dermatoscope devices

The rising advancements in dermatoscope devices are expected to drive the market over the forecast period. Advanced dermatoscope devices incorporate features such as polarized and non-polarized light sources, cross-polarization and adjustable magnification levels, allowing for better visualization and characterization of skin lesions. This leads to increased diagnostic accuracy, particularly in distinguishing between benign and malignant lesions.

Additionally, some advanced dermatoscope devices leverage artificial intelligence (AI) algorithms for automated lesion analysis and decision support. AI-powered features aid in lesion classification, risk stratification and treatment recommendations, complementing the expertise of healthcare providers and potentially improving diagnostic outcomes.

For instance, on January 17, 2024, Privately-held device maker DermaSensor cleared the U.S. Food and Drug Administration approvals for its hand-held device that uses artificial intelligence to detect skin cancer. The Miami-based private company's device - also called DermaSensor - utilizes light and an AI-powered algorithm to help primary care physicians in identifying the presence of cancer in suspicious moles or lesions.

Many modern dermatoscope devices are equipped with digital imaging capabilities, enabling high-resolution image capture and storage. Integration with electronic health records and telemedicine platforms facilitates seamless documentation, analysis and remote consultation, enhancing workflow efficiency and patient care.

Further, the increasing prevalence of various skin cancers and skin diseases, rising FDA approvals for novel devices, increasing awareness about dermatoscope devices and increasing technological advancements in the development of more dermatoscope devices are the factors expected to drive the market over the forecast period.

Restraints

Factors such as the preference for alternative methods, high cost associated with dermatoscope devices, regulatory challenges, limited awareness about dermatoscope devices and technical challenges associated with these devices are the factors expected to hamper the market.

Segment Analysis

The global dermatoscope devices market is segmented based on product type, modality, application, end-user and region.

The digital dermatoscope segment accounted for approximately 39.4% of the dermatoscope devices market share

The digital dermatoscope segment is expected to hold the largest market share over the forecast period. Digital dermatoscopes capture high-resolution images of skin lesions, providing detailed and accurate visual documentation. These images can be magnified, manipulated and stored for further analysis, making them invaluable for monitoring lesion changes over time and facilitating remote consultations.

For instance, on June 6, 2023, DeepX Diagnostics received clearance from the US Food and Drug Administration (FDA) for its digital dermatoscope DermoSight for teledermatology screening of suspect skin cancer lesions in the United States. DermoSight is currently cleared to acquire skin lesion images for teledermatology assessment, like existing digital dermatoscopes. It is also designed for integration with an AI algorithm, empowered by proprietary optical transfer diagnosis (OTD) technology, although the FDA has yet to approve the commercial use of the OTD technology with DermoSight. OTD enables the analysis of lesions on the sub-skin level based on their light-transferring properties. The technology is designed to turn dermatoscopic assessment into a robust, non-invasive and accessible AI-driven tool and to streamline and fast-track skin cancer diagnosis.

Digital dermatoscopes often incorporate advanced features such as polarized or non-polarized light, adjustable magnification and image enhancement algorithms, which enhance the visualization of surface and subsurface structures of the skin. This allows for better characterization of lesions and improves diagnostic accuracy. These devices also enables patients to actively participate in their care by allowing them to view and discuss their skin images with healthcare providers.

Geographical Analysis

North America accounted for approximately 41.3% of the market share

North America region is expected to hold the largest market share over the forecast period owing to the strong presence of major players and rising demand for dermatoscope devices. North America especially the United States is known hub for its strong presence of major players such as medical device companies. This presence of major players in the region aims to develop more technologically advanced dermatoscope devices through digital features and AI algorithms.

In addition, there is an increasing demand for dermatoscope devices due to the increasing prevalence of skin cancers in the region especially in the United States. For instance, according to the American Academy of Dermatology Association, skin cancer is the most common cancer in the United States. Current estimates are that one in five Americans will develop skin cancer in their lifetime. It is estimated that approximately 9,500 people in the U.S. are diagnosed with skin cancer every day. Research estimates that nonmelanoma skin cancer (NMSC), including basal cell carcinoma (BCC) and squamous cell carcinoma (SCC), affects more than 3 million Americans a year. More than 1 million Americans are living with melanoma.

Competitive Landscape

The major global players in the dermatoscope devices market include HEINE Optotechnik GmbH & Co. KG, Optilia Medical, FotoFinder Systems GmbH, Rudolf Riester GmbH, Canfield Scientific, Inc., Firefly Global, Illuco Co., Ltd., DermLite, HILLROM & WELCH ALLYN and KRUPA MEDI SCAN among others.

COVID-19 Impact Analysis

The COVID-19 pandemic significantly impacted the global dermatoscope devices market. The COVID-19 pandemic has caused a massive shift towards telehealth, including teledermatology and teledermoscopy, making these devices more relevant. There have been several studies evaluating patient-directed dermoscopy during a self-skin examination. Some patients postponed seeking medical attention for skin concerns during the pandemic, either due to fear of contracting the virus or logistical challenges associated with accessing healthcare services. As a result, there may have been delays in the diagnosis and treatment of skin conditions, including skin cancer, which could impact the demand for dermatoscope devices in the short term.

Why Purchase the Report?

To visualize the global dermatoscope devices market segmentation based on product type, modality, application, end-user and region as well as understand key commercial assets and players.
Identify commercial opportunities by analyzing trends and co-development
Excel data sheet with numerous data points of dermatoscope devices market-level with all segments.
PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
Product mapping available as excel consisting of key products of all the major players.

The global dermatoscope devices market report would provide approximately 69 tables, 72 figures, and 187 Pages.

Target Audience 2024

Manufacturers/ Buyers
Industry Investors/Investment Bankers
Research Professionals
Emerging Companies

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Product Type
3.2. Snippet by Modality
3.3. Snippet by Application
3.4. Snippet by End-User
3.5. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. Rising Advancements in Dermatoscope Devices
- 4.1.2. Restraints
  - 4.1.2.1. High Cost of the Devices
- 4.1.3. Opportunity
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Unmet Needs
5.6. PESTEL Analysis
5.7. Patent Analysis
5.8. SWOT Analysis

6. COVID-19 Analysis

6.1. Analysis of COVID-19
- 6.1.1. Scenario Before COVID
- 6.1.2. Scenario During COVID
- 6.1.3. Scenario Post COVID
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During the Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion

7. By Product Type

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 7.1.2. Market Attractiveness Index, By Product Type
7.2. Digital Dermatoscope*
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Hybrid Dermatoscope
7.4. Contact Dermatoscope
7.5. Noncontact Dermatoscope

8. By Modality

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Modality
- 8.1.2. Market Attractiveness Index, By Modality
8.2. Handheld Dermatoscopes*
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Desktop Dermatoscopes

9. By Application

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.1.2. Market Attractiveness Index, By Application
9.2. Skin Disease Diagnosis*
- 9.2.1. Introduction
- 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Examination of Skin Lesions
9.4. Others

10. By End-User

10.1. Introduction
- 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 10.1.2. Market Attractiveness Index, By End-User
10.2. Hospitals*
- 10.2.1. Introduction
- 10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
10.3. Specialty Clinics
10.4. Dermatology Centers
10.5. Diagnostic Centers
10.6. Others

11. By Region

11.1. Introduction
- 11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 11.1.2. Market Attractiveness Index, By Region
11.2. North America
- 11.2.1. Introduction
- 11.2.2. Key Region-Specific Dynamics
- 11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Modality
- 11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 11.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 11.2.7.1. U.S.
  - 11.2.7.2. Canada
  - 11.2.7.3. Mexico
11.3. Europe
- 11.3.1. Introduction
- 11.3.2. Key Region-Specific Dynamics
- 11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Modality
- 11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 11.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 11.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 11.3.7.1. Germany
  - 11.3.7.2. UK
  - 11.3.7.3. France
  - 11.3.7.4. Italy
  - 11.3.7.5. Spain
  - 11.3.7.6. Rest of Europe
11.4. South America
- 11.4.1. Introduction
- 11.4.2. Key Region-Specific Dynamics
- 11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Modality
- 11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 11.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 11.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 11.4.7.1. Brazil
  - 11.4.7.2. Argentina
  - 11.4.7.3. Rest of South America
11.5. Asia-Pacific
- 11.5.1. Introduction
- 11.5.2. Key Region-Specific Dynamics
- 11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Modality
- 11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 11.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 11.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 11.5.7.1. China
  - 11.5.7.2. India
  - 11.5.7.3. Japan
  - 11.5.7.4. Australia
  - 11.5.7.5. Rest of Asia-Pacific
11.6. Middle East and Africa
- 11.6.1. Introduction
- 11.6.2. Key Region-Specific Dynamics
- 11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Modality
- 11.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 11.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

12. Competitive Landscape

12.1. Competitive Scenario
12.2. Market Positioning/Share Analysis
12.3. Mergers and Acquisitions Analysis

13. Company Profiles

13.1. HEINE Optotechnik GmbH & Co. KG*
- 13.1.1. Company Overview
- 13.1.2. Product Portfolio and Description
- 13.1.3. Financial Overview
- 13.1.4. Key Developments
13.2. Optilia Medical
13.3. FotoFinder Systems GmbH
13.4. Rudolf Riester GmbH
13.5. Canfield Scientific, Inc.
13.6. Firefly Global
13.7. Illuco Co., Ltd.
13.8. DermLite
13.9. HILLROM & WELCH ALLYN
13.10. KRUPA MEDI SCAN (LIST NOT EXHAUSTIVE)